$PDSB News

PDS Biotechnology Says Lars Boesgaard To Resign As CFO, Principal Financial Officer & Principal Accounting Officer Effective Sept 12; Frank Bedu-Addo Appointed As Interim Principal Financial Officer

PDS Biotech Reports Second Quarter 2026 Financial Results

HC Wainwright & Co. Maintains Buy on PDS Biotechnology, Lowers Price Target to $7

PDS Biotechnology Q2 EPS $(0.18) Misses $(0.13) Estimate

PDS Biotechnology Stock Crashes, Strategic Refocus Pivots to Metastatic Colorectal Cancer Program

PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101

PDS Biotechnology Announces Strategic Refocus To Prioritize PDS0301 In Metastatic Colorectal Cancer; Expects To Advance PDS0301 Through Randomized Phase 2B Development Program Over Next 18 To 24 Months

PDS Biotechnology Establishes Up To $50M At-The-Market Common Stock Offering Program

Here's Why PDS Biotechnology (PDSB) Could be Great Choice for a Bottom Fisher

PDS Biotechnology Corp (PDSB) Q1 2026 Earnings Call Highlights: Strategic Advancements and ...

PDS Biotechnology Q1 Earnings Call Highlights

PDS Biotechnology Corporation Q1 2026 Earnings Call Summary

PDS Biotechnology Q1 2026 Earnings Call: Complete Transcript

PDS Biotech (NASDAQ:PDSB) Posts Narrower Q1 Loss, Pre-Market Rises Over 5%

PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update

PDS Biotechnology Corporation (PDSB) Q1 2026 Earnings Call Transcript

PDS Biotechnology Q1 2026 Earnings Call: Complete Transcript

PDS Biotechnology Q1 EPS $(0.13) Beats $(0.15) Estimate

PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results

HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $15 Price Target